Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs
Big Pharma uses legal tricks like product hopping and REMS abuse to block generic drugs from reaching patients, even when state laws allow substitution. These antitrust violations cost U.S. consumers billions annually.
read more